- Home
- FENG vs PLUR Comparison
FENG vs PLUR Comparison
Compare FENG & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- PLUR
- Stock Information
- Founded
- FENG 1998
- PLUR 2001
- Country
- FENG China
- PLUR Israel
- Employees
- FENG N/A
- PLUR N/A
- Industry
- FENG Broadcasting
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FENG Industrials
- PLUR Health Care
- Exchange
- FENG Nasdaq
- PLUR Nasdaq
- Market Cap
- FENG 32.7M
- PLUR 36.9M
- IPO Year
- FENG 2011
- PLUR N/A
- Fundamental
- Price
- FENG $2.20
- PLUR $3.26
- Analyst Decision
- FENG
- PLUR Strong Buy
- Analyst Count
- FENG 0
- PLUR 1
- Target Price
- FENG N/A
- PLUR $12.00
- AVG Volume (30 Days)
- FENG 4.7K
- PLUR 8.5K
- Earning Date
- FENG 11-13-2025
- PLUR 11-11-2025
- Dividend Yield
- FENG N/A
- PLUR N/A
- EPS Growth
- FENG N/A
- PLUR N/A
- EPS
- FENG N/A
- PLUR N/A
- Revenue
- FENG $101,168,374.00
- PLUR $1,336,000.00
- Revenue This Year
- FENG N/A
- PLUR $97.38
- Revenue Next Year
- FENG N/A
- PLUR $293.97
- P/E Ratio
- FENG N/A
- PLUR N/A
- Revenue Growth
- FENG 5.53
- PLUR 309.82
- 52 Week Low
- FENG $1.28
- PLUR $3.22
- 52 Week High
- FENG $3.65
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- FENG 38.57
- PLUR 29.92
- Support Level
- FENG $2.16
- PLUR $3.22
- Resistance Level
- FENG $2.43
- PLUR $4.00
- Average True Range (ATR)
- FENG 0.06
- PLUR 0.18
- MACD
- FENG -0.01
- PLUR -0.05
- Stochastic Oscillator
- FENG 17.99
- PLUR 4.60
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.